COVID-19 test kit FRCOD 020

IgGIgMSARS-COV-2

The FREND™ COVID-19 IgG/IgM Duo is designed for the qualitative detection of anti-coronavirus IgG and IgM in human serum and plasma (Li-heparinized, EDTA, or citrate) by fluorescence immunoassay (FIA) using the FREND™ System. FREND™ COVID 19 IgG/IgM Duo is an in vitro diagnostic medical device that helps identify coronavirus disease 2019 (COVID-19) infections. KEY FEATURES & BENEFITS - 2 steps | Easy to use - 93.02% & 100% | Positive & Negative Percent Agreement (after 8 days from symptom onset) - Microfluidic Qualitative Immunoassay - LIS connectivity (data management) Total Solution for COVID-19 NanoEntek provides a total solution for the detection and surveillance of COVID-19 infection. En-swer™ COVID-19 RT-PCR Kit detects the presence of SARS-CoV-2 virus itself through real-time reverse-transcription polymerase chain reaction. FREND™ COVID-19 IgG/IgM Duo is a point-of-care testing (POCT) which can be used to check whether patients have developed immune responses to SARS-Cov-2 using human plasma. Microfluidic Qualitative Immunoassay FREND™ COVID-19 IgG/IgM Duo The FREND™ COVID-19 IgG/IgM Duo is a fluorescence immunoassay (FIA) for use with the FREND™ System. It is designed for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 directly from nasopharyngeal swab specimens directly from individuals suspected with COVID-19 by their healthcare provider. Instructions for use With just simple steps of operation, the FREND™ system supports quick decision-making.